EVALUATING LYMPHOCYTE COUNTS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

被引:0
|
作者
Hammoudeh, Lubna [1 ]
Lim-Fat, Mary Jane [2 ]
Cagney, Daniel [3 ]
Aizer, Ayal A. [4 ]
Tanguturi, Shyam [2 ]
Arvold, Nils [5 ]
Mcfaline-Figueroa, Jose [2 ]
Chukwueke, Ugonma [2 ]
Reardon, David [6 ]
Lee, Eudocia [2 ]
Nayak, Lakshmi [2 ]
Rinne, Mikael [2 ]
Ligon, Keith [7 ]
Wen, Patrick [2 ]
Alexander, Brian [2 ]
Rahman, Rifaquat [1 ]
机构
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Radiat Oncol, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA
[5] St Lukes, Duluth, MN USA
[6] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
RADT-25
引用
收藏
页码:186 / 187
页数:3
相关论文
共 50 条
  • [31] Chemoradiation Treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM)
    Cappelli, L.
    Kanyne, A.
    Pan, P. C.
    Cordova, J. S.
    Huang, J.
    Wang, T. J. C.
    Alnahhas, I.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E68 - E68
  • [32] EXPEDITED CHEMORADIATION AFTER LASER INTERSTITIAL THERMAL THERAPY (LITT) IS FEASIBLE AND SAFE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Yu, Jennifer
    Meade, Seth
    Zhao, Ran
    Wei, Wei
    Dashora, Himanshu
    Prayson, Richard
    Grabowski, Matthew
    Stevens, Glen
    Murphy, Erin
    Suh, John
    Chao, Samuel
    Barnett, Gene
    Peereboom, David
    Ahluwalia, Manmeet
    Mohammadi, Alireza
    NEURO-ONCOLOGY, 2024, 26
  • [33] Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma
    Kim, Michelle M.
    Speers, Corey
    Li, Pin
    Schipper, Matthew
    Junck, Larry
    Leung, Denise
    Orringer, Daniel
    Heth, Jason
    Umemura, Yoshie
    Spratt, Daniel E.
    Wahl, Daniel R.
    Cao, Yue
    Lawrence, Theodore S.
    Tsien, Christina I.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (02) : 313 - 319
  • [34] RESPONSE ASSESSMENT USING MULTIPARAMETRIC MRI DURING CHEMORADIATION PREDICTS OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Kim, Michelle
    Aryal, Madhava
    Parmar, Hemant
    Li, Pin
    Schipper, Matthew
    Wahl, Daniel
    Lawrence, Theodore
    Cao, Yue
    NEURO-ONCOLOGY, 2019, 21 : 179 - 179
  • [35] Lymphocyte counts in patients receiving daclizumab HYP in DECIDE
    Wiendl, H.
    Giovannoni, G.
    Greenberg, S.
    Sheridan, J.
    Amaravadi, L.
    McCroskery, P.
    Giannattasio, G.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 266 - 267
  • [36] Absolute Lymphocyte Count in Patients with Glioblastoma Treated with Temozolomide Chemoradiation
    Bamashmos, Anas Ahmed Moahmmed Saeed
    Ali, Assad
    Barnett, Addison
    Sagar, Soumya
    Knusel, Konrad
    Ahluwalia, Manmeet
    NEUROLOGY, 2019, 92 (15)
  • [37] Impact of Delay of Chemoradiation (CRT) in Newly Diagnosed Glioblastoma (GBM) Treated With Stupp Protocol
    Ali, Assad
    Knussel, Konrad
    Barnett, Addison
    Bamashmos, Anas Saeed
    Sagar, Soumya
    Ahluwalia, Manmeet
    NEUROLOGY, 2019, 92 (15)
  • [38] Impact of adjuvant anti-VEGF therapy on treatment-related pseudoprogression in patients with newly diagnosed glioblastoma receiving chemoradiation with or without anti-VEGF therapy
    Pinho, Marco C.
    Polaskova, Pavlina
    Jennings, Dominique
    Wen, Patrick Y.
    Jain, Rakesh K.
    Sorensen, A. Gregory
    Gerstner, Elizabeth Robins
    Batchelor, Tracy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma
    Ironside, Sarah
    Das, Sunit
    Sahgal, Arjun
    Moroney, Claire
    Mainprize, Todd
    Perry, James R.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (11)
  • [40] Everolimus shortens survival of newly diagnosed glioblastoma patients
    Eric T. Wong
    Kenneth D. Swanson
    Journal of Neuro-Oncology, 2018, 140 : 179 - 180